Boston Technology Review
SEE OTHER BRANDS

Your science and technology news from Massachusetts

Boston Technology Review: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Boston Technology Review.

Press releases published on August 13, 2025

RxTran’s Patented Prescription Label Translation Service Sponsor Booth at This Year’s NACDS Total Store Expo

RxTran’s Patented Prescription Label Translation Service Sponsor Booth at This Year’s NACDS Total Store Expo

Attendance critical for raising awareness of the company mission ensuring that all Limited English Proficiency patients receive accurate medication instructions BOSTON, MA, UNITED STATES, August 13, 2025 /⁨EINPresswire.com⁩/ -- RxTran, a division of …

HerAnova Selected to Present Endometriosis Diagnostic Data at  ASRM and AAGL Conferences

HerAnova Selected to Present Endometriosis Diagnostic Data at ASRM and AAGL Conferences

Year-end scientific presentations spotlight progress of HerResolveTM testing in advancing noninvasive, blood-based detection of endometriosis. BOSTON, MA, UNITED STATES, August 13, 2025 /⁨EINPresswire.com⁩/ -- HerAnova Lifesciences, a leader in non- …

HMX Launches Groundbreaking Cognitive AI Agents to Solve AI's Black Box Problem

HMX Launches Groundbreaking Cognitive AI Agents to Solve AI's Black Box Problem

New Agent Builder Merges Human Expertise and Transparent AI for Mission-Critical Decisions BOSTON, MA, UNITED STATES, August 13, 2025 /⁨EINPresswire.com⁩/ -- HMX Corporation, a pioneering leader in explainable artificial intelligence (XAI), today …

Amparo Reports Significant Gains with ChainThat’s BPA Platform

Amparo Reports Significant Gains with ChainThat’s BPA Platform

Amparo Insurance, a US general agency, has announced remarkable efficiency improvements following its Personal Auto product launch on ChainThat’s BPA platform. BOSTON, MA, UNITED STATES, August 13, 2025 /⁨EINPresswire.com⁩/ -- Amparo Insurance, a US-based …

Eightfold AI Recognized as One of HR Executive Magazine’s 2025 Products of the Year

Eightfold AI Recognized as One of HR Executive Magazine’s 2025 Products of the Year

SANTA CLARA, Calif., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Eightfold AI has been named to the 2025 Products of the Year list by HR Executive Magazine and the HR Technology Conference. This annual competition, widely regarded as a benchmark for innovation and …

Evan Kirstel Named #1 Global Internet of Things Thought Leader by Thinkers360

Evan Kirstel Named #1 Global Internet of Things Thought Leader by Thinkers360

Evan Kirstel tops the prestigious 2025 IoT thought leaders list with a perfect score, recognized for global influence, insights, and tech education worldwide BOSTON, MA, UNITED STATES, August 13, 2025 /⁨EINPresswire.com⁩/ -- Evan Kirstel, a globally …

Enovix Shareholder Third Reminder: Early Warrant Expiration Price Condition

Enovix Shareholder Third Reminder: Early Warrant Expiration Price Condition

FREMONT, Calif., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Enovix Corporation (Nasdaq: ENVX, ENVXW) (“Company” or “Enovix”), a leader in advanced silicon battery technology, today announced that the price of its common stock has exceeded $10.50 for seventeen …

Africa Bitcoin Conference Diaspora Edition: What to Expect in Boston this August

Africa Bitcoin Conference Diaspora Edition: What to Expect in Boston this August

ABCD unites the global African diaspora to explore how Bitcoin drives financial freedom, innovation …

Biofrontera Inc. Reports Second Quarter 2025 Financial Results and Provides a Business Update

Biofrontera Inc. Reports Second Quarter 2025 Financial Results and Provides a Business Update

Woburn, MA, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Biofrontera Inc. (NASDAQ:BFRI) (the "Company"), a biopharmaceutical company specializing in the development and commercialization of photodynamic therapy in dermatology, today reported financial results for the …

Applied Therapeutics Reports Second Quarter 2025 Financial Results

Applied Therapeutics Reports Second Quarter 2025 Financial Results

- CMT-SORD program advances; meeting scheduled with the FDA in Q3 2025 to discuss govorestat for the treatment of CMT-SORD - Presented full 12-month clinical results and new topline data from INSPIRE Phase 2/3 trial of govorestat for the treatment of CMT- …

Quorum Announces Q2 2025 Results Release Date, Conference Call and Webcast Details

Quorum Announces Q2 2025 Results Release Date, Conference Call and Webcast Details

CALGARY, Alberta, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Quorum Information Technologies Inc. (TSX-V: QIS) (“Quorum”), a North American SaaS Software and Services company providing essential enterprise solutions that automotive dealerships and Original …

LAVA Reports Second Quarter 2025 Financial Results and Provides Corporate Update

LAVA Reports Second Quarter 2025 Financial Results and Provides Corporate Update

Announced entry into an agreement to be acquired by XOMA Royalty Corporation for between $1.16 and $1.24 per share in cash, plus a contingent value right related to LAVA’s two partnered assets and unpartnered programs Consummation of acquisition expected …

Astrotech to Participate in the H.C. Wainwright 27th Annual Global Investment Conference in September 2025

Astrotech to Participate in the H.C. Wainwright 27th Annual Global Investment Conference in September 2025

AUSTIN, Texas, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Astrotech Corporation (Nasdaq: ASTC) (the “Company” or “Astrotech”) today announced that Thomas B. Pickens III, Chairman and Chief Executive Officer, and Jennifer Cañas, Chief Financial Officer, will host …

SCYNEXIS Reports Second Quarter 2025 Financial Results and Provides Corporate Update

SCYNEXIS Reports Second Quarter 2025 Financial Results and Provides Corporate Update

First new patient dosed in Phase 3 MARIO study following the lifting of the FDA clinical hold, triggering a $10M milestone payment from GSK. An additional $20M milestone will be triggered upon the six month anniversary of the new patient dosing; as …

Onco360 adds Modeyso™ (dordaviprone) to portfolio of Oncology and Rare Cancer therapies as a National Specialty Pharmacy Provider

Onco360 adds Modeyso™ (dordaviprone) to portfolio of Oncology and Rare Cancer therapies as a National Specialty Pharmacy Provider

LOUISVILLE, Ky., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Onco360®, the nation’s leading independent Specialty Pharmacy, has been selected as a pharmacy partner by Jazz Pharmaceuticals for Modeyso™ (dordaviprone). It is indicated for the treatment of adult and …

Aptose Reports Second Quarter 2025 Results

Aptose Reports Second Quarter 2025 Results

Tuspetinib Continues to Demonstrate Excellent Safety and Complete Responses in the TUSCANY Clinical Trial of Tuspetinib in AML Triple Drug Frontline Therapy at 120 mg Dose Cohort Safety Review Committee (CSRC) Recommends Tuspetinib Dose Escalation to 160 …

Opus Genetics Announces Financial Results for Second Quarter 2025 and Provides Corporate Update

Opus Genetics Announces Financial Results for Second Quarter 2025 and Provides Corporate Update

- Positive 12-month Phase 1/2 clinical data in adult cohort and early pediatric clinical data support potential for meaningful vision restoration with OPGx-LCA5 - - FDA grants Regenerative Medicine Advanced Therapy (RMAT) designation for OPGx-LCA5 - - …

Vivani Medical Provides Business Update Including $10M Equity Financing and Reports Second Quarter 2025 Financial Results

Vivani Medical Provides Business Update Including $10M Equity Financing and Reports Second Quarter 2025 Financial Results

Company plans rapid advancement of semaglutide implant NPM-139, following positive weight loss data from an ongoing preclinical study of NPM-139 and promising results from the LIBERATE-1 Phase 1 clinical study of NPM-115 New $10M equity financing to enable …

Orezone Gold Reports Second Quarter 2025 Results

Orezone Gold Reports Second Quarter 2025 Results

All dollar amounts are in USD unless otherwise indicated and abbreviation “M” means million. VANCOUVER, British Columbia, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Orezone Gold Corporation (TSX/ASX: ORE, OTCQX: ORZCF) (“Orezone” or “Company”) is pleased to report …

Alvotech Reports Results for the First Six Months of 2025 and Provides a Business Update

Alvotech Reports Results for the First Six Months of 2025 and Provides a Business Update

Strong performance driven by over 200% growth in product revenues year-on-year Best quarter in Alvotech’s history in terms of operating cash flows Continued expansion of commercial partnerships for pipeline assets Alvotech listed on Nasdaq Stockholm Market …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions